In focus
HistoIndex and A*STAR Partner to Advance AI-Driven Therapeutics for Fibrotic Diseases
Singapore's A*STAR and digital pathology pioneer HistoIndex have signed an MoU to collaborate on preclinical evaluations of fibrotic disease therapies. The partnership leverages AI-powered tissue analysis to accelerate drug development.
Read the story
